Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Lucemyra
Generic Name
Lofexidine Hydrochloride
Active Ingredient
LofexidineCategory
Other
Salt Form
Hydrochloride
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .2 mg/1 | TABLET, FILM COATED | ORAL | 78670-050 |
Detailed information about Lucemyra
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Lucemyra, you must consult a qualified healthcare professional.
Lofexidine is a central alpha-2 adrenergic agonist indicated for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. It works by reducing the release of norepinephrine to alleviate physical symptoms of withdrawal.
The dosing of lofexidine is highly specific and must be tailored to the severity of the withdrawal symptoms and the patient's tolerance.
Lofexidine is primarily cleared by the kidneys. In patients with kidney disease, the drug can accumulate, increasing the risk of side effects like bradycardia (slow heart rate) and hypotension (low blood pressure).
Since lofexidine is metabolized by the liver, patients with hepatic impairment require monitoring.
Clinical studies of lofexidine did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently. However, because elderly patients are more likely to have decreased renal function and are more sensitive to blood pressure changes, they should start at the lowest possible dose with frequent monitoring of vital signs.
If you miss a dose of lofexidine, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within 2 hours), skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of a dangerous drop in blood pressure or heart rate.
An overdose of lofexidine can be life-threatening.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation can cause your blood pressure to rise rapidly.
Lofexidine affects the autonomic nervous system, which can lead to several predictable side effects. The most common include:
> Warning: Stop taking Lofexidine and call your doctor immediately if you experience any of these serious symptoms:
Lofexidine is not intended for long-term use. Most clinical trials have limited exposure to 14 days. Consequently, the long-term side effects are not well-characterized. However, chronic use of alpha-2 agonists can lead to:
However, the FDA does emphasize the risk of hypotension, bradycardia, and QT prolongation in the 'Warnings and Precautions' section of the official label. It is critical that patients are monitored for these cardiovascular effects throughout the duration of treatment.
Report any unusual symptoms to your healthcare provider. Monitoring your heart rate and blood pressure at home can be a helpful way to track how your body is responding to the medication.
Lofexidine is a potent medication that significantly impacts the cardiovascular system. It should only be used as part of a comprehensive treatment program for opioid withdrawal. Patients must be aware that while lofexidine treats the physical symptoms of withdrawal, it does not treat the underlying addiction. Furthermore, after completing withdrawal with lofexidine, a patient's tolerance to opioids is significantly reduced. Resuming opioid use at previous doses can lead to a fatal overdose.
No FDA black box warnings for Lofexidine.
Before and during treatment with lofexidine, your healthcare provider will likely perform the following:
Lofexidine can cause significant drowsiness, dizziness, and blurred vision. You should not drive, operate heavy machinery, or engage in potentially dangerous activities until you know how the medication affects you. Most patients should avoid these activities during the first few days of treatment.
Alcohol should be strictly avoided while taking lofexidine. Alcohol increases the sedative effects of the drug and can further lower blood pressure, increasing the risk of fainting and accidents.
Do not stop taking lofexidine suddenly. Your doctor will provide a tapering schedule to gradually reduce the dose over 2 to 4 days. If you experience a sudden headache, confusion, or blurred vision during the tapering process, contact your doctor immediately as these may be signs of high blood pressure.
> Important: Discuss all your medical conditions with your healthcare provider before starting Lofexidine, especially if you have a history of heart disease, kidney disease, or stroke.
While there are few absolute contraindications, certain combinations are extremely high-risk:
Lofexidine is not known to interfere significantly with common laboratory tests (such as glucose or cholesterol tests). However, it may affect specialized tests for catecholamines (like norepinephrine) in the urine or blood, as the drug naturally suppresses these levels. Always inform the lab if you are taking this medication.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is necessary to prevent dangerous cardiovascular complications.
Lofexidine must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a physician:
While not strictly documented, patients who have had severe adverse reactions to other alpha-2 adrenergic agonists (such as clonidine or guanfacine) should be monitored closely, as they may experience similar side effects with lofexidine. However, an allergy to clonidine does not automatically mean an allergy to lofexidine, as their chemical structures differ.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of fainting or heart rhythm disorders, before prescribing Lofexidine.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or have any history of organ dysfunction.
Lofexidine is a central alpha-2 adrenergic receptor agonist. Its primary site of action is the locus coeruleus, a nucleus in the pons (part of the brainstem) that is the principal site for synthesis of norepinephrine in the brain. During opioid withdrawal, the locus coeruleus becomes hyperactive. Lofexidine binds to the alpha-2A receptors on the surface of these neurons. This binding inhibits the enzyme adenylate cyclase, which leads to a decrease in intracellular cAMP. The end result is the inhibition of the neuron's firing and a significant reduction in the release of norepinephrine. By 'quieting' this area of the brain, lofexidine reduces the systemic 'adrenergic storm' that causes withdrawal symptoms.
| Parameter | Value |
|---|---|
| Bioavailability | ~90% |
| Protein Binding | ~55% |
| Half-life | 12 - 17 hours |
| Tmax | 3 - 5 hours |
| Metabolism | Hepatic (CYP2D6, CYP1A2, CYP3A4) |
| Excretion | Renal 92%, Fecal <1% |
Lofexidine is classified as a central alpha-2 adrenergic agonist. It is therapeuticially categorized as a detoxification adjunct. Related medications include clonidine (used off-label for withdrawal) and guanfacine (used for ADHD and hypertension).
Common questions about Lucemyra
Lofexidine is primarily used to reduce the physical symptoms of opioid withdrawal in adults who are stopping the use of opioids abruptly. These symptoms include things like muscle aches, stomach cramps, sweating, and a rapid heart rate. It is important to note that it is not a cure for addiction itself, but rather a supportive tool to make the detoxification process more tolerable. It is typically used for a short duration, usually between 7 and 14 days. Unlike some other treatments, lofexidine is not an opioid and does not carry a risk of abuse.
The most common side effects of lofexidine include low blood pressure (hypotension), a slow heart rate (bradycardia), and significant drowsiness or sedation. Many patients also report feeling dizzy or lightheaded, especially when standing up quickly from a sitting or lying position. Dry mouth is another very frequent side effect. Because of these effects, it is crucial to stay hydrated and move slowly when changing positions. Most of these side effects are most intense during the first few days of treatment and tend to improve as the body adjusts or as the dose is tapered.
No, you should strictly avoid drinking alcohol while taking lofexidine. Both alcohol and lofexidine are central nervous system depressants, meaning they slow down brain activity. Combining them can lead to dangerous levels of sedation, respiratory depression (slowed breathing), and a severe drop in blood pressure that could lead to fainting or accidents. Alcohol can also worsen the dehydration that sometimes accompanies opioid withdrawal. Always wait until the medication is completely out of your system—usually several days after your last dose—before consuming alcohol.
The safety of lofexidine during pregnancy has not been well-established, as there are no comprehensive studies in pregnant women. Animal studies have suggested potential risks to the fetus at high doses, such as lower birth weight. For pregnant women struggling with opioid use, the standard of care is usually maintenance therapy with methadone or buprenorphine rather than abrupt withdrawal. If lofexidine is considered, it must be a decision made closely with a high-risk obstetrician. The risks of untreated opioid withdrawal to the fetus must be weighed against the unknown risks of the medication.
Lofexidine begins to work relatively quickly, with peak levels in the bloodstream reached within 3 to 5 hours after the first dose. However, many patients begin to feel some relief from the 'autonomic' symptoms of withdrawal—like sweating and racing heart—within 1 to 2 hours. It is designed to be taken four times a day to maintain a steady effect throughout the day and night. While it works quickly on physical symptoms, it may take a few days of consistent dosing to find the optimal balance that manages withdrawal without causing too much drowsiness.
You should not stop taking lofexidine suddenly, as doing so can cause a 'rebound' effect. When the medication is stopped abruptly, the suppression of the nervous system is lifted too quickly, which can lead to a sharp and dangerous increase in blood pressure. This is often accompanied by symptoms like headache, anxiety, and a rapid pulse. To avoid this, your healthcare provider will give you a tapering schedule to slowly reduce your dose over 2 to 4 days. Always follow this schedule exactly to ensure a safe transition off the medication.
If you miss a dose of lofexidine, you should take it as soon as you remember. However, if it is already close to the time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Never take two doses at once to make up for a missed one, as this significantly increases the risk of severe side effects like fainting or a dangerously slow heart rate. If you miss multiple doses, contact your healthcare provider for instructions on how to safely restart the medication.
Weight gain is not a recognized side effect of lofexidine. Because the medication is only intended for short-term use (up to 14 days), it does not typically have enough time to affect metabolic processes or appetite in a way that leads to significant weight changes. In fact, many people undergoing opioid withdrawal may experience temporary weight loss due to decreased appetite, nausea, or diarrhea. If you notice significant weight changes while taking this medication, it is more likely related to the withdrawal process itself or other underlying health factors rather than the lofexidine.
Lofexidine can interact with several other medications, so it is vital to provide your doctor with a full list of everything you take. It should be used with extreme caution alongside other drugs that lower blood pressure, slow the heart rate (like beta-blockers), or cause sedation (like benzodiazepines). There is also a specific concern regarding medications that affect the heart's rhythm (QT interval), such as methadone or certain antidepressants. Your doctor will check for these interactions to ensure that the combination is safe for your heart and nervous system.
As of 2024, lofexidine is primarily available under the brand name Lucemyra in the United States. While the drug itself has been around for many years in other countries, the specific FDA-approved formulation is relatively new to the U.S. market. Generic versions may become available in the future as patent protections expire, but currently, it is often a brand-name-only prescription. Patients should check with their insurance provider regarding coverage, as brand-name specialty medications can sometimes have higher co-pays or require prior authorization.
Other drugs with the same active ingredient (Lofexidine)